Disclaimer
Product Inserts on this website are made available for ilustration purposes only. When using one of our test kits, one must use the insert provided with the kit itself.
Herpes Simplex Virus (HSV)
The Herpesviruses occur worldwide in humans and animals with several hundred herpesviridae species. Common to all herpesviruses is a high level of generalized contamination (60-90% carriers) and the ability to persist in a latent state in the body over long periods.
The Herpes-simplex-Virus (HSV) is the pathogen that causes a vesicular exanthem (fever blisters, herpes labiales or genitalis), encephalitis and a generalized infection in newborns (herpes neonatorum). They have dsDNA genomes.
Herpes simplex viruses are classified in types 1 and 2:
Initial infection with herpes simplex virus Type 1 usually occurs in early childhood. HSV type 1 is transmitted by contact and possible by smear infection as well. The portal of entry is normally the oral mucosa ("oral type") and the infection usually manifests as a gingivostomatitis. The viruses wander along axons into the CNS, where they persist in latent state in the trigeminal (Gasseri) ganglion. As with all herpesviruses the pathogen remains in the macroorganism permanently after the primary infection. Following reactivation (endogenous recidivation), the viruses follow the same route back to the periphery, where they cause the familiar vesicular exanthema ("fever blister", herpes labialis). Despite established immunity such recidivations can manifest repeatedly because the virus wander within the nerve cells and do not enter the intercellular space, thus remaining beyond the reach of the immune defences. Possible complications include keratoconjunctivitis and a highly lethal form of encephalitis.
The initial infection with herpes simplex virus Type 2 normally affects the urogenital area ("genital type") and can be contracted despite an existing HSV type 1 infection. HSV type 2 persists in the latent state in the lumbosacral ganglia or periphel tissues, from where it causes episodes of manifest herpes genitalis. Neurological complications are very rare and more benign than in HSV type 1. On the other hand, infections of newborn children (herpes neonatorum) e.g. in cases of maternal genital herpes, are feared for their high lethality rate.
Transmission of HSV type 2 usually occurs during sexual intercourse, so that infections are generally not observed until after puberty.
Species | Disease | Symptoms | Mechanism of infection |
HSV type 1(Herpes labialis) | Oral herpes Usually: gingivostomatitis complications: e.g. keratoconjunctivitis, encephalitis recidivation: Herpes labialis | After an incubation period of ca. 1 week: vesicular exanthema (fever blister) at the mouth or face accompanied by feeling of sickness, fever, difficulties in swallowing | Transmission by droplets |
HSV type 2 (Herpes genitalis) | Genital Herpes | Self-healing-lesions, influenza-like symptoms (fever, swollen glands), ulcers | Sexually transmitted disease |
Neonatal Herpes | encephalitis | Infection during birth |
Infections may be diagnosed by:
- Microscopy:
- Serology: Determination of specific antibodies based on the ELISA-technique
NovaLisaTM HSV 1/HSV 2/HSV 1+2 IgG/IgM ELISA:
The NovaLisaTM HSV1/HSV2/HSV 1+2 IgG/IgM ELISA is intended for the qualitative determination of IgG-/IgM-class antibodies against Herpes simplex Virus Type 1 resp. Type 2 resp. Type 1+2 in human serum or plasma (citrate).
Antigens:
HSV 1: Recombinant gG1 protein of HSV Type 1
HSV 2: Recombinant gG2 protein of HSV Type 2
HSV 1+2: purified membrane antigens of strain Mac Intyre (ATCC VR-539) (HSV1) and strain Ms (ATCC VR-540) (HSV2)
Specific performance characteristics:
HSV1:
Intraassay | Interassay | Sensitivity | Specificity | |||||
n | Mean | CV % | n | Mean | CV % | |||
IgG | 20 24 | 0.45 1.88 | 3.4 3.7 | 12 12 | 12.8 48.3 | 3.6 4.9 | 87.5% | 94.1% |
IgM | 20 24 | 1.3 0.46 | 7.7 6.9 | 14 14 | 37 12 | 4.2 5.6 | >95% | >95% |
HSV2:
Intraassay | Interassay | Sensitivity | Specificity | |||||
n | Mean | CV % | n | Mean | CV % | |||
IgG | 20 24 | 0.45 1.88 | 3.4 3.7 | 12 12 | 12.3 42.5 | 2.7 4.9 | >95% | >95% |
IgM | 20 24 | 1.3 0.46 | 7.7 6.9 | 14 14 | 37 12 | 4.2 5.6 | >95% | >95% |
HSV1+2:
Intraassay | Interassay | Sensitivity | Specificity | |||||
n | Mean | CV% | n | Mean | CV% | |||
IgG | 13 | 1.08 | 5.8 | 3 | 1.05 | 3.6 | >95% | >95% |
IgM | 13 | 1.22 | 8.8 | 4 | 1.24 | 11.4 | >95% | >95% |
External comparison study Novagnost® (is equivalent to NovaTec):
"In summary, the novel Novagnost® enzyme immunoassays for the determination of HSV-1 and HSV-2 IgG show a very good correlation with ELISA and immunoblot reference procedures approved by the US FDA. The novel procedures can be recommended for reliable automatic type-specific diagnosis of latent HSV infection."
(A. Sauerbrei, P. Wutzler/ Journal of Virological Methods 144 (2007) 138-142)
Order information:
ELISA | Number of determinations | Product number |
HSV Typ 1 IgG | 96 | HSV1G0500 |
HSV Typ 1 IgM | 96 | HSV1M0500 |
HSV Typ 2 IgG | 96 | HSV2G0540 |
HSV Typ 2 IgM | 96 | HSV2M0540 |
HSV Typ 1+2 IgG | 96 | HSVG0250 |
HSV Typ 1+2 IgM | 96 | HSVM0250 |





